Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer.

Jhanelle E GrayAndreas SaltosTawee TanvetyanonEric B HauraBenjamin C CreelanScott J AntoniaMichael R ShafiqueHong ZhengWenjie DaiJames J SallerZhihua ChenNishan TchekmedyianKristen GoasRam ThapaTheresa A BoyleDung-Tsa ChenAmer A Beg

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)

Pembrolizumab plus vorinostat was well tolerated and demonstrated preliminary antitumor activity despite progression on prior ICI treatment.

Keyphrases

advanced non small cell lung cancer
squamous cell carcinoma
small cell lung cancer